Literature DB >> 17313549

Live/real time three-dimensional transthoracic echocardiographic assessment of left ventricular volumes, ejection fraction, and mass compared with magnetic resonance imaging.

Xin Qi1, Bryan Cogar, Ming Chon Hsiung, Navin C Nanda, Andrew P Miller, Pridhvi Yelamanchili, Oben Baysan, Yu Shu Wu, Gong Yau Lan, James S Ko, Charles H Cheng, Chang Chyi Lin, Chien Ming Huang, Wei Hsian Yin, Mason Shing Young.   

Abstract

Due to reliance upon geometric assumptions and foreshortening issues, the traditionally utilized transthoracic two-dimensional echocardiography (2DTTE) has shown limitations in assessing left ventricular (LV) volume, mass, and function. Cardiac magnetic resonance imaging (MRI) has shown potential in accurately defining these LV characteristics. Recently, the emergence of live/real time three-dimensional (3D) TTE has demonstrated incremental value over 2DTTE and comparable value with MRI in assessing LV parameters. Here we report 58 consecutive patients with diverse cardiac disorders and clinical characteristics, referred for clinical MRI studies, who were evaluated by cardiac MRI and 3DTTE. Our results show good correlation between the two modalities.

Entities:  

Mesh:

Year:  2007        PMID: 17313549     DOI: 10.1111/j.1540-8175.2006.00428.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  16 in total

Review 1.  Echocardiography in pericardial diseases: new developments.

Authors:  Gabriella Veress; Dali Feng; Jae K Oh
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

2.  Real-time three-dimensional echocardiographic assessment of left ventricular remodeling index in patients with hypertensive heart disease and coronary artery disease.

Authors:  Ming Chen; Jing Wang; Mingxing Xie; Xinfang Wang; Qing Lv; Lei Wang; Yan Li; Manli Fu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

3.  Current clinical applications of transthoracic three-dimensional echocardiography.

Authors:  Luigi P Badano; Francesca Boccalini; Denisa Muraru; Lucia Dal Bianco; Diletta Peluso; Roberto Bellu; Giacomo Zoppellaro; Sabino Iliceto
Journal:  J Cardiovasc Ultrasound       Date:  2012-03-27

Review 4.  LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice.

Authors:  Anderson C Armstrong; Samuel Gidding; Ola Gjesdal; Colin Wu; David A Bluemke; João A C Lima
Journal:  JACC Cardiovasc Imaging       Date:  2012-08

5.  Assessing the Cardiac Toxicity of Chemotherapeutic Agents: Role of Echocardiography.

Authors:  Timothy C Tan; Marielle Scherrer-Crosbie
Journal:  Curr Cardiovasc Imaging Rep       Date:  2012-12-01

6.  Real-time three-dimensional echocardiography as a novel approach to quantify left ventricular dyssynchrony: a comparison study with phase analysis of gated myocardial perfusion single photon emission computed tomography.

Authors:  Nina Ajmone Marsan; Maureen M Henneman; Ji Chen; Claudia Ypenburg; Petra Dibbets; Stefano Ghio; Gabe B Bleeker; Marcel P Stokkel; Ernst E van der Wall; Luigi Tavazzi; Ernest V Garcia; Jeroen J Bax
Journal:  J Am Soc Echocardiogr       Date:  2008-01-28       Impact factor: 5.251

Review 7.  Cardiac toxicity of anticancer agents.

Authors:  Alessandro Colombo; Carlo Cipolla; Marta Beggiato; Daniela Cardinale
Journal:  Curr Cardiol Rep       Date:  2013-05       Impact factor: 2.931

Review 8.  Performance of 3-dimensional echocardiography in measuring left ventricular volumes and ejection fraction: a systematic review and meta-analysis.

Authors:  Jennifer L Dorosz; Dennis C Lezotte; David A Weitzenkamp; Larry A Allen; Ernesto E Salcedo
Journal:  J Am Coll Cardiol       Date:  2012-05-15       Impact factor: 24.094

9.  Comparison of contrast enhanced three dimensional echocardiography with MIBI gated SPECT for the evaluation of left ventricular function.

Authors:  Bernard Cosyns; David Haberman; Steven Droogmans; Sandrine Warzée; Philippe Mahieu; Eric Laurent; Marie Moonen; Sophie Hernot; Patrizio Lancellotti
Journal:  Cardiovasc Ultrasound       Date:  2009-06-16       Impact factor: 2.062

10.  Cardiotoxicity of cancer therapeutics: current issues in screening, prevention, and therapy.

Authors:  Richard J Sheppard; Jenna Berger; Igal A Sebag
Journal:  Front Pharmacol       Date:  2013-03-12       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.